HPV infection caused by cervical cancer, cervical intraepithelial neoplasia lesions, polyps, warts, etc.
Conditions
Interventions
Case series:Targeted Cellular Immunotherapy
Sponsors
Hefei Ruichengsheng Biotechnology Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients' HPV test should be positive and should be determine which HPV subtype the patient was (or were) infected with. While meeting this condition, patients should also following the requirements: (1) not having a serious autoimmune disease; (2) not having T lymphoma; (3) being unable to be allergic to cytokines; (4) non-lactation and pregnancy; (5) not suffering There are serious infectious diseases; (6) organ function is not exhausted; (7) there is no history of organ transplantation.
Exclusion criteria
Exclusion criteria: (1) the patient has a negative HPV DNA test; (2) the patient has a severe autoimmune disease; (3) the patient has a T lymphoma; (4) the patient is allergic to cytokines; (5) the patient is During treatment, during lactation and pregnancy; (6) the patient has a serious infectious disease; (7) the patient's organ failure; (8) the patient has had a history of organ transplantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HPV positive to negative;Specific CTL;Cytokines such as IL-2 and IFN-?;Cell subgroups such as CD4+, CD8+, CD3+CD56+ cells; | — |
Countries
China
Contacts
Public ContactJU ZHANG
Hefei Ruichengsheng Biotechnology Co., Ltd.
Outcome results
None listed